Children’s Medical Center Dallas Ranked Among Best Children’s Hospitals, Nationally Recognized in All Pediatric Specialties by U.S. News & World Report
This is the eighth consecutive year of national recognition across every specialty; only children’s hospital in the region to earn the distinction DALLAS , Oct. 7, 2025 /PRNewswire/ — Children’s HealthSM is proud to announce that Children’s Medical Center Dallas has once again been named among the nation’s best pediatric hospitals by U.S. News & World […]
Batbox Grand Opening Set for October 15th in Dallas, Texas
Next-generation sports bar with immersive baseball simulators debuts in Addison’s Village on the Parkway DALLAS, Oct. 7, 2025 /PRNewswire/ — Batbox, the sports technology company reinventing how the world plays and connects through baseball, will open its first U.S. flagship, Batbox Dallas, on Wednesday, October 15, 2025. Located in Addison’s Village on the Parkway, the […]
TORL BioTherapeutics Secures $96M Series C Financing and Presents Updated Phase 1 Results of Novel Claudin 6 Targeted Antibody-Drug Conjugate TORL-1-23 at the 2025 European Society of Medical Oncology Congress
Secured $96M Series C Financing; Total Raised Since 2019 Founding Exceeds $450M Proceeds Fund the Clinical Development of TORL-1-23, Currently in a Registrational Phase 2 Study for Claudin 6 Positive (CLDN6+) Platinum-Resistant Ovarian Cancer and in Phase 1 for other CLDN6+ Cancers including Non-Small Cell Lung Cancer Updated Data for TORL-1-23 in Patients with CLDN6+ […]
Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment
GAITHERSBURG, Md., Oct. 7, 2025 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the marketing authorization for its COVID-19 vaccine, Nuvaxovid® to Sanofi, in the European Union (EU) enabling Sanofi to take full responsibility for commercial and regulatory activities in the EU. The transfer triggered a milestone payment of $25 million to […]
Peer AI Raises $12.1 Million to Accelerate Drug Approvals with an Intelligent Regulatory Workflow
Specialized AI agents combined with precise human-in-the-loop control points create accurate, high-quality regulatory documents up to 94% faster SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ — Peer AI, a leading agentic AI platform for life sciences regulatory documentation, today announced $12.1 million in total funding, led by Flare Capital Partners and SignalFire. Other investors included Greycroft, Atria, Alumni […]
OppFi Announces its Third Quarter 2025 Earnings Conference Call
CHICAGO, Oct. 7, 2025 /PRNewswire/ — OppFi Inc. (NYSE: OPFI) (“OppFi” or the “Company”), a tech-enabled digital finance platform that partners with banks to offer financial products and services to everyday Americans, will report financial results for its third quarter 2025 before the market open on Wednesday, October 29, 2025. Management will host a conference […]
Lilly und führende Alzheimer-Experten fordern auf der Alzheimer Europe Konferenz dringende Maßnahmen zur Schließung von Diagnoselücken
Erkenntnisse aus der Praxis von Klinikern bieten neue Einblicke in die gesellschaftlichen und systemischen Hindernisse für die Diagnose der Alzheimer-Krankheit (AD) in Europa[1] Eine Umfrage zeigt, dass zwar über 70 % der Fachleute die Bedeutung von Biomarker-Tests für Alzheimer anerkennen, aber weniger als einer von fünf Patienten diese Tests erhält[1] Experten auf der Konferenz von […]
Lilly and Leading Alzheimer’s Disease Experts Call for Urgent Action to Close Diagnostic Gaps at Alzheimer Europe Conference
Real-world evidence from clinicians offers new insights into societal and systemic barriers to diagnosis of Alzheimer’s disease (AD) across Europe[1] Survey shows that while over 70% of specialists agree on the importance of biomarker testing for AD, fewer than one in five patients receive these tests[1] Experts at Alzheimer Europe conference call for urgent health […]
IAS STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Integral Ad Science (Nasdaq: IAS) Proposed Stockholder Buyout and Encourages Investors to Contact the Firm
PHILADELPHIA, Oct. 7, 2025 /PRNewswire/ — Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Integral Ad Science (Nasdaq: IAS) (“IAS” or the “Company”) shareholders. Click here for additional information: https://kaskelalaw.com/case/integral-ad-science/ On September 24, 2025, IAS announced that it had agreed to be acquired by private equity firm […]
Lilly et d’éminents experts de la maladie d’Alzheimer appellent à une action urgente pour combler les lacunes en matière de diagnostic lors de la conférence Alzheimer Europe
Les données concrètes fournies par les cliniciens donnent un nouvel aperçu des obstacles sociétaux et systémiques au diagnostic de la maladie d’Alzheimer (MA) en Europe[1] L’enquête montre que si plus de 70 % des spécialistes reconnaissent l’importance des tests de biomarqueurs pour la maladie d’Alzheimer, moins d’un patient sur cinq bénéficie de ces tests[1]. Les […]